The intestinal absorption of chondroitin sulfate (CS) and its hydrolysate, particularly the disaccharides (Di-CS), was investigated by using human intestinal epithelial Caco-2 cell monolayers. Although the transepithelial transport of CS was not detectable, dose-and time-dependent transport of Di-CS was observed. The transport of Di-CS was proved to be energy-independent and its permeability increased inversely with the transepithelial electrical resistance (TER) value of the Caco-2 cell monolayers. The transport rate for Di-CS was also increased by treating the cell monolayers with such tight junction-opening agents as interferon-. These results suggest that Di-CS permeated across the Caco-2 cell monolayers mainly via the paracellular pathway. The permeability of Caco-2 cell monolayers to authentic chondroitin 4-sulfate disaccharides (Di-4S), chondroitin 6-sulfate disaccharides (Di-6S) and chondroitin 0-sulfate disaccharides (Di-0S) was almost same, suggesting that sulfation did not affect the transport rate of Di-CS.
Chondroitin sulfate (CS), a high-molecular-weight polysaccharide, is found in connective tissues as a component of proteoglycans and consists of repeating (1 ! 4)-linked disaccharide units of -D-glucuronic acid linked (1 ! 3) to N-acetyl--D-galactosamine. The two most common isomers, CS-A and CS-C, are respectively sulfated at C-4 and C-6 of the galactosamine residue. 1) Several reports have shown that CS had anti-inflammation characteristics. [2] [3] [4] CS is therefore used as an ingredient for dietary supplements taken as an alternative medicine to treat osteoarthritis and as a potential chondroprotective drug. CS is also approved and regulated as a symptomatic slow-acting drug for this disease (SYSADOA) in Europe and some other countries. 5) An in vitro study has shown CS to reduce IL-1-induced nuclear factor-B (NF-B) translocation in chondrocytes. 6) CS and their oligosaccharides (oligo-CS), when absorbed, can thus be expected to modulate immune cell functions beneath the epithelium and suppress inflammatory reactions.
Although the intestinal absorption of CS has been controversial, 5, 7) a variety of analytical methods, including pharmacokinetic studies performed on humans, have demonstrated that CS can be absorbed by an oral route. 3, [8] [9] [10] [11] [12] [13] Furthermore, several in vivo 10, [12] [13] [14] and in vitro 14) studies have suggested that the structure and molecular size of CSs strongly influence their absorption and bioavailability, higher absorption and bioavailability being reported for lower-molecular-weight CSs.
Small CSs, including CS-oligosaccharides (oligo-CS) and CS-disaccharides (Di-CS), have recently been demonstrated to play a critical role in immune-modulating functions. It has been reported that Di-CSs protected nerve cells from inflammation-associated neurodegeneration 15, 16) and retinal cells from elevated intraocular pressure in aged and immunocompromised rats. 17) Ebert et al. have shown that Di-CS stimulated microglia to adopt a novel regulatory phenotype. 18) However, until now, there have been few reports describing the detailed properties and mechanisms that manage the transepithelial transport of Di-CS. More studies on the absorption mechanisms of Di-CS will be beneficial to evaluate the bioavailability of CS after an oral administration.
We attempted in this present study to disclose the mechanism for intestinal transepithelial transport of Di-CS by using Caco-2 cell monolayers that have been employed to analyze the transport mechanisms of many dietary compounds, including amino acids, 19) peptides, 20) vitamins, 21) and oligosaccharides.
22)

Materials and Methods
Materials. The Caco-2 cell line was obtained from the American Type Culture Collection (Rockville, MD, USA). Dulbecco's modified Eagle's medium (DMEM) was purchased from Wako (Osaka, Japan). Fetal bovine serum, Hanks' balanced salt solution (HBSS) and cytochalasin B (Cyto B) were purchased from Sigma (St. Louis, MO, USA). Penicillin-streptomycin (10,000 U/ml and 10 mg/ml in y To whom correspondence should be addressed. Tel: +81-3-5841-5127; Fax: +81-3-5841-8026; E-mail: ams316@mail.ecc.u-tokyo.ac.jp Abbreviations: CS, chondroitin sulfate; Cyto B, cytochalasin B; Di-CS, CS-disaccharide; IFN-, interferon-; oligo-CS, CS-oligosaccharides; TER, transepithelial electrical resistance 0.9% sodium chloride, respectively) and non-essential amino acids (NEAA) were purchased from Gibco (Gaithersburg, MD, USA). The type-I collagen solution was purchased from Nitta Gelatin (Osaka, Japan), and phosphate-buffered saline (PBS) was from Nissui Pharmaceutical Co. (Tokyo, Japan). Sodium azide was from Kanto Chemical Co. (Tokyo, Japan), and interferon-(IFN-) was from Peprotech (Rocky Hill, NJ, USA). Chondroitin sulfate A (CS-A) was purchased from Calbiochem (Darmstadt, Germany), and chondroitin sulfate C (CS-C) was from Wako (Osaka, Japan). Chondroitinase ABC from Proteus vulgaris, fetal bovine serum (FBS) and Di-CSs (Di-4S, Di-6S, and Di-0S, Fig. 1 ) were obtained from Sigma (St. Louis, MO, USA). All the other chemicals were of reagent grade.
Cell culture. The Caco-2 cells were maintained at a density of 2 Â 10 5 cells in a 100-mm dish with DMEM containing 10% FBS, 1% NEAA, 40 U/ml of penicillin and 40 mg/ml of streptomycin. The cells were cultured at 37 C in humidified air containing 5% CO 2 , and the culture medium was renewed on alternate days. When the cells had reached confluence (6-7 d after seeding), they were passaged by trypsinization with 0.1% trypsin and 0.02% EDTA in PBS. All of the cells used in this study were between passages 40 and 60. A transepithelial transport experiment was performed with Caco-2 cells cultured at a density of 1 Â 10 5 cells per well in 12-well Transwell inserts (12 mm diameter and 0.4 mm pore size; Corning Costar, NY, USA) that had been precoated with collagen. The cell monolayers for all experiments were continuously cultured for 14 d.
Preparation of oligo-CSs. CS-A or CS-C (400 mg) dissolved in 10 ml of PBS was hydrolyzed with 0.4 U of chondroitinase ABC at 37 C for 48 h. 23) The oligo-CS solution was heated for 5 min to denature the proteins after hydrolysis. Di-4S and Di-6S in the oligo-CS solutions were determined by strong anion-exchange high-performance liquid chromatography (SAX-HPLC). 7, 14) Measurement of the transepithelial electrical resistance (TER). The integrity of the Caco-2 cell monolayers was evaluated by measuring TER with Millicell-ERS equipment (Millipore, MA, USA). TER of the monolayers was measured before and after an assay sample had been added to the insert (apical side).
Transepithelial transport experiments for CSs and Di-CSs. The apical side of Caco-2 cell monolayers that had been cultured in a Transwell insert was washed twice with HBSS. The insert and basal chamber were respectively filled with 0.5 and 1.5 ml of HBSS, before being incubated at 37 C for 0.5 h. After removing half the amount of HBSS in the apical insert, 0.25 ml of a CS sample solution in HBSS was added to the insert, and the solution incubated at 37 C for appropriate times. The amounts of intact CS and Di-CS in the basal solution were respectively measured by the carbazole method 24) and SAX-HPLC. HBSS without glucose (Glc (À) HBSS) was used in the transport experiment for intact CSs, since the presence of free glucose would interfere with the determination of CS by the carbazole assay.
HPLC analysis of Di-CS. The SAX-HPLC analysis was performed by using a Bio-Rad BioLogic DuoFlow system equipped with a QuadTec UV/Vis detector and a Hitachi D-2500 Chromato-Integrator. BioLogic DuoFlow Version 4.00 software (Bio-Rad) was used to control the apparatus and to collect data. SAX-HPLC was performed with a Hypersil SAX column (4:6 mm Â 250 mm, 5 mm) from Thermo Hypersil-Keystone (Belefonte, PA, USA) according to the procedure reported by Sim et al. 7) After the sample had been injected, the column was washed with water (adjusted to pH 3.5 with 1 N hydrochloric acid) for 4.155 min corresponding to one column volume (CV). Di-CSs were then eluted under a linear gradient of 0-1.0 M NaCl (pH 3.5) for 41.55 min (10 CV), and the profile was monitored at 232 nm.
The injected amount of every sample was 50 ml. Before measuring the amount of Di-CSs in the basal chamber of the Transwell insert, the total basal solution was concentrated 5 times by lyophilization and filtered with a polytetrafluoroethylene (PTFE) filter unit (0.45 mm pore size). The amount of Di-CSs in each sample was measured by an unsaturated Chondro-Disaccharide kit (C-Kit; for HPLC) from Seikagaku (Tokyo, Japan).
Carbazole assay of CSs. A sodium tetraborahydrate solution was prepared by dissolving 0.95 g of sodium tetraborahydrate in 100 ml of sulfuric acid. The carbazole solution was made by dissolving 0.125 g of carbazole in 100 ml of ethanol. A CS test solution (1 ml) was added to the sodium tetraborahydrate solution (5 ml) in test tubes, and then the mixture was vigorously shaken. The tubes were next heated for 15 min in boiling water and cooled to room temperature. Carbazole (0.2 ml) was then added to the tubes and they were shaken again. The test tubes were once again heated in boiling water for 15 min and finally cooled to room temperature. The absorption of each sample was measured at 530 nm. Seven concentrations of a D-glucurono-6,3-lactone solution (0, 0.5, 1, 5, 10, 15, and 20 mg/ml) were utilized as the standard solutions. 24) Statistical analysis. Each result is expressed as the mean AE SD. Differences among the experimental data were assessed by a one-way analysis of variance (ANOVA) and subsequent F-protected Fisher's least significant difference.
Results
Transepithelial transport of Di-CS across Caco-2 cell monolayers
Intact CS-A and CS-C were hydrolyzed for 48 h with chondroitinase ABC, and Di-CSs in the digests were determined by SAX-HPLC. The oligo-CS-A fraction thus prepared contained 30.4% Di-4S and 7.9% Di-6S, whereas the oligo-CS-C fraction contained 9.0% Di-4S and 17.3% Di-6S. Each hydrolysate was diluted with HBSS to 4 mg/ml, giving final concentrations of Di-4S of 1.2 mg/ml in the CS-A hydrolysate and Di-6S of 0.7 mg/ml in the CS-C hydrolysate. Since the pure commercially available Di-CS was too costly, the CS hydrolysates prepared in this way were used for the transport experiments. The transport rate of Di-CSs was 
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Di-6S CS-C Fig. 1 . Structures of the CS Disaccharides (Di-0S, Di-4S and Di-6S).
Di-4S, the disaccharide unit of CS-A, is sulfated on C-4 of the galactosamine, whereas Di-6S, the disaccharide unit of CS-C, is sulfated on C-6 of the galactosamine. Di-0S carries no sulfated group. evaluated by measuring the percentage of (Di-CS transported to the basal chamber/the total amount of Di-CS added to the apical chamber).
The permeability of Di-CS across the Caco-2 cell monolayers was compared with that of the intact CS. The CS-A and CS-C hydrolysates were separately added to the apical chamber of Transwell inserts, and the amounts of Di-4S and Di-6S in the basal chamber were respectively determined. After incubating for 3 h, the transport rate of Di-4S and Di-6S had reached about 0.6%. However, intact CS-A and CS-C could not be detected in the basal chamber ( Fig. 2A) .
Different concentrations of the CS-A hydrolysate were then added to the apical chamber of Transwell inserts, and the amount of Di-4S in the basal chamber was determined, after incubating the cells for 3 h. The transport rates of Di-4S were about 0.3%, 0.6%, and 1.0% when the CS-A hydrolysate was added at concentrations of 2, 4, and 8 mg/ml, respectively (Fig. 2B) . Although the transport rate was slightly lower at the highest concentration of 8 mg/ml, it would be reasonable to think that a saturation mechanism was not significantly involved in this transport. After incubating the CS-A hydrolysate at 4 mg/ml in the apical chamber of Transwell inserts for 1, 2, and 3 h, the respective transport rates of Di-4S were about 0.25%, 0.35%, and 0.6% (Fig. 2C) . These results suggest that the transepithelial transport of Di-CS through the Caco-2 cell monolayers was linearly correlated with the concentration and time.
Energy-dependence of the transepithelial transport of Di-CS
To reveal the energy-dependence of the transport, the effect of a metabolic inhibitor on the transepithelial transport of Di-CS was examined by using the CS hydrolysates. Treating the Caco-2 cell monolayers with sodium azide (NaN 3 ) did not affect the transepithelial transport of Di-4S (Fig. 3A) or Di-6S (Fig. 3B) through the Caco-2 cell monolayers, suggesting that an energydependent transport mechanism was not involved in the transport of Di-CS.
Together with the findings that the transepithelial transport of Di-CS linearly increased with increasing Di-CS concentration (Fig. 2B ), the energy-independent characteristics of Di-CS transport (Fig. 3 ) strongly suggest that the main pathway for Di-CS permeability was the paracellular route.
Correlation between the Di-CS permeability and TER value of the Caco-2 cell monolayers Cytochalasin B (Cyto B) and such cytokines as interferon-(IFN-) are known to affect the tight junctions of epithelial cell layers and increase the paracellular permeability. 25, 26) When Caco-2 cell monolayers were treated with Cyto B (5 mg/ml) on the apical side, their TER value was decreased by almost 70% (Fig. 4A top) . The CS-A hydrolysate was applied to the apical chamber of the Caco-2 cell monolayers, and the amounts of Di-4S and Di-6S in the basal chamber were measured after a 3-h incubation. The permeation rate of Di-4S was substantially increased by the Cyto B treatment, the rate being higher than 650% (Fig. 4A  bottom) . Both the HPLC peak areas of Di-4S and Di-6S in the basal chamber were markedly increased (Fig. 4B) .
Similarly, the TER value of the Caco-2 cell monolayers was decreased to almost 70% of the control value by treating the monolayers with IFN-(100 ng/ml) in the basal chamber (Fig. 5A top) . The permeated Di-4S level increased to 235% under this condition (Fig. 5A  bottom) . Both the HPLC peak areas of Di-4S and Di-6S in the basal chamber significantly increased, the ratio of Di-4S/Di-6S being unchanged by the IFN-treatment (Fig. 5B) . The correlation of the transepithelial transport A, Intact CSs and oligo-CSs at the same concentration (4 mg/ml) were incubated for 3 h on the apical side of the Caco-2 cell monolayers, and the permeated CSs and Di-CSs were respectively determined by a carbazole assay and SAX-HPLC. B, Oligo-CS-A at different concentrations was added to the apical side, and the permeated Di-4S was determined by SAX-HPLC after a 3-h incubation. C, Oligo-CS-A (4 mg/ml) was added to the apical side, and the permeated Di-4S was similarly determined. Each value is the mean AE SD (n ¼ 3).
of Di-CSs with the TER value of the cell monolayers also suggests that paracellular diffusion was the main transport mechanism.
Effect of sulfate residues on the transepithelial transport of Di-CSs in Caco-2 cell monolayers
The paracellular transport rate of the three Di-CSs was examined by using authentic Di-CSs as samples. Di-0S, Di-4S, and Di-6S were added to the apical chamber of Transwell inserts, and the amounts of Di-CSs in the basal chamber were determined by SAX-HPLC after culturing the cells for 3 h. The amounts of Di-4S, Di-6S, and Di-0S in the basal chamber were approximately 0.5% and not significantly different among the samples (Fig. 6) , indicating that the sulfate residue did not affect the permeability to Di-CSs.
Discussion
The high molecular weight and negative charge density of CS are thought to be the factors which suppress the transepithelial transport of CS. In this present study, we introduced CS disaccharides, the smallest oligosaccharide unit of CS, to investigate their transepithelial transport across the intestinal epithelial Caco-2 cell monolayers.
Active transport, which is energy-dependent, is a popular absorption process for ions and small molecules. Although no mammalian transporter for oligosaccharides has yet been found, we examined whether there would be any energy-dependent transport system for Di-CS in Caco-2 cells. The metabolic inhibitor, sodium azide, however, did not affect the transport rate of Di-4S and Di-6S (Fig. 3) . This means that active transport was not involved in the transport of Di-CSs.
IFN-and Cyto B are known to increase the paracellular passive diffusion across the intestinal epithelial cell monolayers by altering the cytoskeletal structure which results in opening tight junctions. 22, 25, 26) The permeability of the Caco-2 cell monolayers to Di-4S and Di-6S was markedly increased when the TER value of the monolayers was reduced by Cyto B (Fig. 4) and also by IFN- (Fig. 5) . Sim After equilibrating with HBSS for 0.5 h, the Caco-2 cell monolayers were treated with HBSS containing NaN 3 (10 mM) for another 0.5 h. The CS hydrolysate (oligo-CS-A or oligo-CS-C, 4 mg/ml) in HBSS with NaN 3 (10 mM) was added to the apical side of the cell monolayers. The amount of permeated Di-CS was determined by SAX-HPLC after incubating for 3 h. Each value is the mean AE SD (n ¼ 4). After equilibrating with HBSS for 0.5 h, the Caco-2 cell monolayers were treated with HBSS containing Cyto B (5 mg/ml) for another 0.5 h. The CS hydrolysate containing Di-CSs (4 mg/ml) in HBSS with Cyto B (5 mg/ml) was added to the apical side. After incubating for 3 h, the TER value of the Caco-2 cell monolayers was measured (A, top), and the amount of permeated Di-4S was determined by HPLC (A, bottom) . B, HPLC patterns of Di-4S and Di-6S. Di-CSs in the CS-A hydrolysate used for the transport experiment (B, left); Di-CSs in the basal solution without the Cyto B treatment (B, middle); Di-CSs in the basal solution with the Cyto B treatment (B, right). Each value is the mean AE SD (n ¼ 4). ÃÃ corresponds to p < 0:01 versus the control group. values and accordingly increased the transport of CSs across Caco-2 cell monolayers. 23) These results suggest that the most plausible mechanism for Di-CSs permeation through Caco-2 cell monolayers was paracellular transport.
Paracellular transport is passive diffusion through small pores at the tight junctions, and is known to be dependent on the charge and size of the molecule being transported. 27) Furthermore, it has been reported that cations more easily passed across the tight junction pores than anions, probably because of the ionic properties of the tight junction pores. [28] [29] [30] [31] The paracellular diffusion rate of Di-CSs might therefore be affected by the degree of sulfation. Moreover, partial desulfation of this sulfated polyanion in humans was found after the intestinal absorption of CS. 9, 11) Studying the absorption process of Di-CS with different degrees of sulfation will be necessary to investigate the effect. There is one sulfur group carried on Di-4S and Di-6S, whereas no sulfur group on Di-0S (Fig. 1) . Using these three types of Di-CS, we investigated whether the sulfur group would affect the transepithelial transport of CS disaccharides. Our data indicate, however, that the permeability of the three different disaccharides was not significantly different (Fig. 6 ). This may suggest that the sulfur group is not the key factor determining the transepithelial transport of Di-CSs. Moreover, neither desulfated nor other structurally-modified Di-CSs were detected after the permeation experiments with Di-4S or Di-6S.
Although the transport of intact CSs was not detectable, about 0.6% of Di-CS added to the apical chamber was transported to the basal chamber in 3 h (Fig. 2) . This value may be low compared with the permeability to such other paracellular diffusive compounds across the Caco-2 cell monolayer as the hypotensive tripeptide, Val-Pro-Pro, which has been reported to be transported more than 10 times faster. 20) It is important to evaluate the in vivo absorption of the compound from the data for the in vitro permeability experiments. Several reports have shown a possible correlation between the oral absorption of drugs and their permeability across Caco-2 cell monolayers. Artursson 32) has reported that the transport parameter, P app , was useful for estimating the drug permeability across Caco-2 cell monolayers. Good correlation of the P app value with the permeability of the rat ileum was demonstrated in that study. The permeability of hydrophilic drugs was shown to be markedly lower than that of hydrophobic drugs, and it was obvious that the permeability of hydrophilic drugs was particularly underestimated when the Caco-2 cell system was used to calculate the P app value. Good correlation has also been observed when the oral absorption of drugs in humans was compared with their P app values by Artursson and Karlsson. 33) They found that the drugs with a P app value higher than 1 Â 10 À6 were transcellularly transported and completely absorbed in humans, whereas the drugs with a P app value of 0:1{1 Â After authentic Di-0S, Di-4S, and Di-6S solutions (4 mg/ml) had been added to the apical side of the Caco-2 cell monolayers, and the inserts incubated for 3 h, the permeated Di-CSs were determined by SAX-HPLC. Each value is the mean AE SD (n ¼ 3).
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À6 were incompletely absorbed, because they were absorbed by the paracellular pathway. Percentage values of absorption in humans, 16% and 50%, were respectively reported for the compounds with P app values of 0:18 Â 10 À6 (mannitol) and 0:20 Â 10 À6 (atenolol). Yee 34) has proposed the ranking of compounds from the P app value obtained by Caco-2 cell monolayers; namely, those compounds with P app < 1 Â 10 À6 , between 1{10 Â 10 À6 , and >10 Â 10 À6 can be respectively classified as poorly (0-20%), moderately (20-70%), and well (70-100%)-absorbed compounds.
We calculated the P app value for pure Di-CS based on the permeability data (Fig. 6 ) obtained by using Caco-2 cells (the TER value was 402 Ácm 2 ). The calculated P app value was about 0:21 Â 10 À6 cm/s. According to the ranking proposed by Yee, 34) this value should be classified as representing a ''poorly absorbed'' compound. However, based on the data by Artursson, 32, 33) this value is almost the same as that of atenolol which has been reported to show 50% absorption from an oral administration in humans. This difference in the estimation of paracellularly transported compounds would be due to the different tight-junction permeability of the Caco-2 cell monolayers. Yee 34) has described that the paracellular absorption was about 4-fold higher with his system than that of Artursson's group.
The TER value, a marker of the tight-junction permeability, of Caco-2 cell monolayers is varied widely depending on the source, passage number, and culture conditions of the cells. The TER value of the Caco-2 cell monolayers used in our study was higher than that of the monolayers used by Artursson (260 Ácm 2 ) 32) and others. This suggests that our Caco-2 cell system substantially underestimated the absorption of Di-CSs. Furthermore, the intestinal epithelium is a tissue with active immunological reactions and is frequently exposed to such cytokines as IFN-. Since the paracellular permeability is significantly enhanced by a cytokine treatment (Fig. 5) , the intestinal absorption of Di-CS can be expected to be much higher in vivo than that estimated in vitro. In conclusion, our results demonstrate that Di-CSs, the smallest units of CSs, can be paracellularly absorbed in the intestines, although the absorption rate may not be very high.
The next question may be whether Di-CSs can be produced in the gastrointestinal tract after orally dosing intact CSs. A thorough in vitro investigation by Barthe et al. 35) of the sites of CS degradation and absorption in rats has shown that CS was degraded to Di-CSs in the contents of the colon, and particularly the cecum, while there was no degradation in the contents of the stomach or small intestine or in any of the other tissues. Using 14 C-radiolabelled CS, Barthe et al. 35) also documented that CS was transported in a low amount across the small intestine in the intact form, whereas a higher amount of radioactivity was transported in both the colon and cecum, most of this radioactivity being in the form of degradation products, the disaccharides. Although we still do not know whether the degradation to Di-CS is a prerequisite for the absorption of CS, the results of this study suggest that CS is degraded to Di-CS in the distal gastrointestinal tract, probably by the enzymes in the intestinal flora, following the higher amount of Di-CS transported there.
The higher bioavailability of CS from an oral administration is a prerequisite for the immune-modulating activity of CS. Although the rate and degree of intact CS degradation in the gastrointestinal tract are still unclear, orally administering a CS hydrolysate may be helpful to supply oligo-CSs, including Di-CSs. Since the anti-inflammatory activity of Di-CS is likely to be much higher than that of intact CS, 36) further studies on the immune-modulating characteristics of Di-CSs would be worthwhile.
